Doximity, Inc. Class A (DOCS)

Doximity, Inc. (DOCS) stock has experienced significant volatility in the past six months. The share price saw a substantial decline of 55.98% from May 7, 2025, to May 6, 2026, and was down approximately 41.3% year-to-date in 2026. In February 2026, Doximity reported Q3 fiscal 2026 results that beat Wall Street's expectations, but the stock plummeted due to weaker-than-expected Q4 fiscal 2026 revenue guidance attributed to industry-wide policy headwinds, specifically Most Favored Nation agreements. The resignation of CFO Anna Bryson further contributed to investor uncertainty. Despite these challenges, the company's board authorized a new $500 million share repurchase program.

While Doximity has historically experienced an upfront annual buying season, recent policy headwinds and Most Favored Nation agreements have disrupted demand patterns. These factors led to delays in annual budget releases and a lower percentage of annual budgets being deployed upfront, creating a timing mismatch in revenue recognition. Therefore, recent industry-wide policy changes have significantly impacted and disrupted the typical demand seasonality for Doximity's products and services.

Doximity, Inc. operates as a digital platform for medical professionals in the United States, providing cloud-based tools for collaboration, patient care coordination, virtual visits, medical news, career management, and administrative tasks. The company serves physicians, nurse practitioners, physician assistants, and medical students, offering marketing, hiring, and telehealth solutions to pharmaceutical manufacturers and healthcare systems. As of 2021, Doximity had over 2 million registered members, including a significant portion of U.S. physicians, nurse practitioners and physician assistants.

Doximity, Inc.'s geographic footprint is primarily concentrated within the U.S. healthcare market. The company's digital platform is tailored for U.S. medical professionals, and its network of licensed clinicians is focused across all 50 states. Doximity's principal executive offices are located in San Francisco, California.

Doximity generally maintains a strong brand reputation within the medical professional community, indicated by its differentiated product offering and efficient customer acquisition. The platform is widely adopted, with a significant percentage of U.S. physicians, nurse practitioners, and physician assistants as members. In November 2023, Doximity enhanced its reputation by releasing DocDefender, a free service designed to remove physicians' personal information from public websites. However, the company faces competitive pressures from platforms like LinkedIn and discussions regarding its practice of pre-populating profiles for clinicians.

Doximity, Inc. (DOCS) has a diverse ownership structure, including institutional, retail, and individual investors. Approximately 48.39% of the company's stock is owned by Institutional Investors, 2.66% by Insiders, and 48.95% by Public Companies and Individual Investors. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, Capital World Investors, William Blair Investment Management, Llc, Clearbridge Investments, LLC, State Street Corp, Geode Capital Management, Llc, Baillie Gifford & Co, Deutsche Bank Ag, and Citadel Advisors Llc. Morgenthaler Venture Partners IX LP is noted as the largest individual Doximity shareholder.